|
Sign In to gain access to subscriptions and/or personal tools.
|
Palate Morphology and Fetal Movements in Mice After DPH
Brlce E. Walker
Anatomy Department, Michigan State University, East Lansing, Michigan 48824
Effects of DPH on fetal development were studied using a dose which produced 65% cleft palate in the CD-1 strain. Generalized developmental retardation and diminution of fatal muscular movements occurred at the early fetal stage. Intermediate stages of palate closure persisted to term, indicating interference with palatine shelf rotation.
REFERENCES
- Smith, D.W.: Teratogenicity of Anticonvulsive Medications, Am J Dis Child 131: 1337-1339, 1977.[Abstract/Free Full Text]
- Massey, K.M.: Teratogenic Effects of Diphenylhydantoin Sodium, J Oral Ther Pharm 2:380-385, 1966.
- Meadow, S.R.: Congenital Abnormalities and Anticonvulsant Drugs, Proc Roy Soc Med 63:48-49, 1970.[Medline]
[Order article via Infotrieve]
- Speidel, B.D., and Meadow, S.R.: Maternal Epilepsy and Abnormalities of the Fetus and Newborn. Lancet 2:839-843, 1972.[Medline]
[Order article via Infotrieve]
- Starreveld-Zimmerman, A.A.E.; Vander Kolk, W.J.; Elshore, J.; and Meinardi, H.: Teratogenicity of Antiepileptic Drugs, Clin Neurol Neurosurg 77:81-95, 1974.[CrossRef]
- Hanson, J.W., and Smith, D.W.: The Fetal Hydantoin Syndrome, J Pediatr 87: 285-290, 1975.[CrossRef][Medline]
[Order article via Infotrieve]
- Pashayan, H.; Pruzansky, D.; and Pruzansky, S.: Are Anticonvulsants Teratogenic? Lancet 2:702-703, 1971.[Medline]
[Order article via Infotrieve]
- Gibson, J.E., and Becker, B.A.: Teratogenic Effects of Diphenylhydantoin in Swiss-Webster and A/J Mice, Proc Soc Exp Biol Med 128:905-909, 1968.[CrossRef][Medline]
[Order article via Infotrieve]
- Fritz, H.: The Effect of Cortisone on the Teratogenic Action of Acetylsalicylic Acid and Diphenylhydantoin in the Mouse, Separatum Experientia 32:721-722, 1976.
- Harbison, R.D., and Becker, B.A.: Diphenylhydantoin Teratogenicity in Rats, Toxicol Appl Pharmacol 22:193-200, 1972.[CrossRef][Medline]
[Order article via Infotrieve]
- Mirkin, B.L.: Diphenylhydantoin: Placental Transport, Fetal Localization, Neonatal Metabolism, and Possible Teratogenic Effects, J Pediatr 78:329-337, 1971.
- Gabler, W.L., and Hubbard, G.L.: The Distribution of 5, 5-Diphenylhydantoin (DPH) and its Metabolites in Maternal and Fetal Rhesus Monkey Tissues, Arch Int Pharmacodyn 200:222-230, 1972.
- Stevens, M.W., and Harbison, R.D.: Placental Transfer of Diphenylhydantoin: Effects of Species, Gestational Age, and Route of Administration, Teratology 9: 317-326, 1974.
- Waddell, W.J., and Mirkin, B.L.: Distribution and Metabolism of Diphenylhydantoin-14C in Fetal and Maternal Tissues of the Pregnant Mouse, Biochem Pharmacol 21:547-552,1972.[Medline]
[Order article via Infotrieve]
- Harbison, R.D., and Becker, B.A.: Comparative Embryotoxicity of Diphenylhydantoin and Some of its Metabolites in Mice, Teratology 10:237-242, 1974.[CrossRef][Medline]
[Order article via Infotrieve]
- Bogoch, S., and Dreyfus, J. (eds): The Broad Range of Use of Diphenylhydantoin, New York: The Dreyfus Medical Foundation, Vol I, 1970.
- Bogoch, S., and Dreyfus, J. (eds): A Supplement to the Broad Range of Use of Diphenylhydantoin, New York: The Dreyfus Medical Foundation, Vol II, 1975.
- Schardein, J.L.; Dresner, A.J.; Hentz, D.L.; Petrere, J.A.; Fitz-Gerald, J.E.; and Kurtz, S.M.: The Modifying Effect of Folinic Acid on Diphenylhydantoin-Induced Teratogenicity in Mice, Toxicol Appl Pharmacol 24:150-158, 1973.[CrossRef][Medline]
[Order article via Infotrieve]
- Walker, B.E., and Quarles, J.: Effects of Anti-inflammatory Steroids on Mouse Embryonic Movements During Palatal Development, J Dent Res 54:1200-1206, 1975.[Abstract/Free Full Text]
- Walker, B.E., and Patterson, A.: Induction of Cleft Palate in Mice by Tranquilizers and Barbiturates, Teratology 10: 159-163, 1974.[CrossRef][Medline]
[Order article via Infotrieve]
- Walker, B.E.: Correlation of Embryonic Movement with Palate Closure in Mice, Teratology 2:191-198, 1969.[CrossRef][Medline]
[Order article via Infotrieve]
- Walker, B.E., and Fraser, F.C.: Closure of Secondary Palate in Three Strains of Mice, J Embryol Exp Morph 4:176-189, 1956.
- Walker, B.E.: Effects on Palate Development of Mechanical Interference with the Fetal Environment, Science 130:981, 1959.[Abstract/Free Full Text]
- Walker, B.E., and Quarles, J.: Palate Development in Mouse Embryos After Tongue Removal, Archs Oral Biol 21:405-412, 1976.
- Walker, B.E., and Patterson, A.: Palate Development After Tongue Removal in Cortisone-treated Mice, Teratology 17: 51-56, 1978.[Medline]
[Order article via Infotrieve]
- Lessard, J.L.; Wee, E.L.; and Zimmerman, E.F.: Presence of Contractile Proteins in Mouse Fetal Palate Prior to Shelf Elevation, Teratology 9:113-125, 1974.[CrossRef][Medline]
[Order article via Infotrieve]
- Walker, B.E., and Fraser, F.C.: The Embryology of Cortisone-induced Cleft Palate, J Embryol Exp Morph 5:201-209, 1957.
- Walker, B.E., and Crain, B., JR.: Effects of Hypervitaminosis A on Palate Development in Two Strains of Mice, Amer J Anat 107: 49-58, 1960.[CrossRef][Medline]
[Order article via Infotrieve]
- Walker, B.E., and Crain B., JR.: Abnormal Palate Morphogenesis in Mouse Embryos Induced by Riboflavin Deficiency, Proc Soc Exp Biol Med 107:404-406, 1961.[CrossRef][Medline]
[Order article via Infotrieve]
- Callas, G., and Walker, B.E.: Palate Morphogenesis in Mouse Embryos After X-irradiation, Anat Rec 145:61-71, 1963.[CrossRef][Medline]
[Order article via Infotrieve]
- Walker, B.E.: Cleft Palate Production in Mice With a Therapeutic-equivalent Dose of Triamcinolone, Science 149:862-863, 1965.[Abstract/Free Full Text]
- Goldstein, A.: Biostatistics, An Introductory Text, New York: The Macmillan Company, 1964, p. 144.
- Harbison, R.D., and Becker, B.A.: Relation of Dosage and Time of Administration of Diphenylhydantoin to its Teratogenic Effect in Mice, Teratology 2:305-312,1969.[CrossRef][Medline]
[Order article via Infotrieve]
- Miller, R.P., and Becker, B.A.: Teratogenicity of Oral Diazepam and Diphenylhydantoin in Mice, Toxicol Appl Pharmacol 32:53-61, 1975.[CrossRef][Medline]
[Order article via Infotrieve]
- Anderson, R.J., and Raines, A.: Suppression of Cerebellar Evoked Potentials by a Peripheral Action of Diphenylhydantoin, Arch Int Pharmacodyn 218:144-155. 1975.
- Origuchi, Y.; Nonaka, I.; Ueno, T.; and Usuku, G.: Ultrastructural Changes in the Cerebellum of Young Rats Having Received Diphenylhydantoin During the Embryonal Stage, Kumamoto Med J 28:84-93, 1975.[Medline]
[Order article via Infotrieve]
- Anderson, R.J., and Raines, A.: Suppression by Diphenylhydantoin of Afferent Discharges Arising in Muscle Spindles of the Triceps Surae of the Cat, J Pharmacol Exp Ther 191:290-299, 1974.[Abstract/Free Full Text]
- Millichap, J.G., and Boldrey, E.E.: Studies in Hyperkinetic Behavior II. Laboratory and Clinical Evaluations of Drug Treatments. Neurology 17:467-471, 519, 1967.[Medline]
[Order article via Infotrieve]
- Martz F.; Failinger,C. IIII; and Blake, D.A.: Phenyltoin Teratogenesis: Correlation Between Embryopathic Effect and Covalent Binding of Putative Arene Oxide Metabolite in Gestational Tissue, J Pharm Exp Ther 203:231-239, 1977.[Abstract/Free Full Text]
- Gillette, J.R.; Menard, R.H.; and Stripp, B.: Active Products of Fetal Drug Metabolism, Clin Pharmacol Ther 14:680-692, 1973.[Medline]
[Order article via Infotrieve]
Journal of Dental Research, Vol. 58, No. 7,
1740-1747 (1979)
DOI: 10.1177/00220345790580071701

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M Katsumata, C Gupta, M. Baker, C. Sussdorf, and A. Goldman
Diphenylhydantoin: an alternative ligand of a glucocorticoid receptor affecting prostaglandin generation in A/J mice
Science,
December 24, 1982;
218(4579):
1313 - 1315.
[Abstract]
[PDF]
|
 |
|
|
|